Pharmaceutical and Biotechnology EvaluatePharma forecast that R&D spending by pharmaceutical companies will rise 1.0% this year to $134 billion, according to a June 2011 report. From now until 2016, R&D spending by drug companies is expected to grow an average of 2.5% annually to total $147 billion. EvaluatePharma forecasted prescription drug revenues to have a […]

This month, the EPA finalized US standards for mercury and air toxics emissions from power plants. The regulations are expected to affect 1,100 coal-fired units and 300 oil-fired units at a total of 600 power plants. Power plants are responsible for approximately 50% of mercury emissions and 77% of acid gas emissions. The standards provide […]

As silicon-based photolithography reaches its feasible limits resulting in leaking electricity and rising manufacturing costs, manufacturers are searching for a new approach to make semiconductors. To make smaller circuits more quickly and less expensively, Intel and IBM are seeking to reduce the size of the smallest component from 32 nm to 7 nm using carbon […]

More often than not, scientists are unable to reproduce medical research results. The lack of reproducibility is likely due to more complicated experiments as laboratory methods evolve, the use of different equipment and materials by different studies, the high number of variables present in a study, authors not presenting all information to other researchers, and […]

The World Steel Association’s October 2011 short-range outlook predicts that worldwide apparent steel use, which it defines as steel deliveries from domestic producers and importers and not from inventories, will increase 6.5% to 1,398 million metric tons (mmt) in 2011, down from 15.1% growth last year. Global steel demand should grow 5.4% in 2012. China […]